6.72
Personalis Inc Aktie (PSNL) Neueste Nachrichten
Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal - BioSpace
Personalis (PSNL) Publishes Promising Study on Cancer Detection Method - GuruFocus
Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® - Business Wire
Personalis, Inc. (NASDAQ:PSNL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Growth Report: Is Personalis Inc showing insider buyingEarnings Growth Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Personalis (NASDAQ:PSNL) Rating Increased to Hold at Wall Street Zen - MarketBeat
Momentum Shift: Is Personalis Inc benefiting from interest rate changesJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Is Personalis Inc. stock attractive after correctionTrade Risk Summary & Weekly High Momentum Picks - Naître et grandir
Personalis Stock Pre-Market (-5.3%): FY26 Guidance Overshadows Q4 EPS Beat - Trefis
Morgan Stanley Has Lowered Expectations for Personalis (NASDAQ:PSNL) Stock Price - MarketBeat
PSNL: Morgan Stanley Maintains Equal-Weight, Lowers Price Target - GuruFocus
Personalis, Inc. $PSNL Stake Boosted by ARK Investment Management LLC - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Short Interest Up 21.2% in February - MarketBeat
Personalis (NASDAQ:PSNL) Shares Gap DownTime to Sell? - MarketBeat
Will Personalis Inc. outperform small cap indexesBear Alert & Free Verified High Yield Trade Plans - mfd.ru
Breaking Down Personalis: 5 Analysts Share Their Views - Sahm
Personalis, Inc. (NASDAQ:PSNL) Q4 2025 Earnings Call Transcript - Insider Monkey
Personalis (NASDAQ:PSNL) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Personalis 2025 Financial Results: Revenue, Loss, and 2026 ForecastNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Personalis, Inc. (PSNL) Stock Analysis: Exploring a Promising 24.98% Upside with Innovative Cancer Genomics - DirectorsTalk Interviews
Personalis (NASDAQ:PSNL) Price Target Raised to $12.00 at Needham & Company LLC - MarketBeat
Personalis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Needham raises Personalis stock price target on reimbursement wins By Investing.com - Investing.com Nigeria
Needham raises Personalis stock price target on reimbursement wins - Investing.com Australia
PSNL Stock Sees Price Target Increase by Needham | PSNL Stock Ne - GuruFocus
Personalis stock price target reaffirmed at $13 by BTIG on MRD growth - Investing.com South Africa
Personalis Q4 Earnings Call Highlights - MarketBeat
Personalis Inc (PSNL) Q4 2025 Earnings Call Highlights: Robust C - GuruFocus
Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights - BioSpace
Personalis Inc (PSNL) Q4 2025 Earnings Call Highlights: Robust Clinical Growth Amidst Revenue ... By GuruFocus - Investing.com Canada
Personalis (NASDAQ:PSNL) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Personalis: Q4 Earnings Snapshot - theheraldreview.com
Personalis (PSNL) Q4 2025 Earnings Call Transcript - AOL.com
Earnings call transcript: Personalis Q4 2025 sees EPS beat but revenue miss - Investing.com
Personalis (PSNL) Offers FY26 Revenue Forecast Below Expectations - GuruFocus
Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates - Nasdaq
PSNL Achieves Strong Q4 Revenue and Prepares for Significant Gro - GuruFocus
Personalis Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Progyny Inc. (PGNY) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
[10-K] Personalis, Inc. Files Annual Report | PSNL SEC FilingForm 10-K - Stock Titan
Personalis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Earnings Breakdown: Personalis Q4 - Benzinga
Personalis (NASDAQ: PSNL) details 2025 results and 2026 growth plan - Stock Titan
Personalis, Inc. Provides Earnings Guidance for the Full Year of 2026 - marketscreener.com
Personalis earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada
Personalis: Overview of Fourth Quarter Financial Results - Bitget
[Form 4] Personalis, Inc. Insider Trading Activity - Stock Titan
Personalis (PSNL) CEO gains 33,333 performance-based stock options - Stock Titan
How Personalis Inc. stock performs in weak economyJuly 2025 Macro Moves & Entry Point Confirmation Alerts - mfd.ru
Personalis (NASDAQ:PSNL) Shares Down 4.8%Should You Sell? - MarketBeat
Aberdeen Group plc Increases Stock Position in Personalis, Inc. $PSNL - MarketBeat
Personalis (PSNL) to Release Earnings on Thursday - MarketBeat
Personalis Receives Medicare Coverage for NeXT Personal in Lung Cancer Surveillance - Clinical Lab Products
Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference - BioSpace
Personalis (NASDAQ:PSNL) Trading Up 6.2%Time to Buy? - MarketBeat
Personalis, Inc. (PSNL) ctDNA Test Predicts TNBC Relapse Risk Post-Therapy - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):